BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 29
• 30

• Business

  Cologuard® revenue and completed tests increased 87 percent to $90.3 million and 186,000

  Exact Sciences Corp. announced that the company generated revenue of $90.3 million and completed approximately 186,000 Cologuard tests during the quarter ended Mar. 31, 2018. First-quarter 2018 revenue and Cologuard test volume both grew 87 percent from 2017.

  April 26, 2018

   · 

  12 min read
• Business

  Ocular Therapeutix™ to Report First Quarter 2018 Financial Results

  Ocular Therapeutix™, Inc. announced that it will report first quarter ended March 31, 2018 financial results on Tuesday, May 8, 2018.

  April 26, 2018

   · 

  2 min read
• Business

  Tandem Diabetes Care Reports First Quarter 2018 Financial Results

  Tandem Diabetes Care®, Inc. reported its financial results for the quarter ended March 31, 2018.

  April 26, 2018

   · 

  8 min read
• Drug Development

  ImmunoGen Announces Successful Completion of Interim Analysis for FORWARD I Phase 3 Trial of Mirvetuximab Soravtansine in Platinum-Resistant Ovarian Cancer

  ImmunoGen, Inc. announced that the FORWARD I Phase 3 registration trial evaluating mirvetuximab soravtansine as a single-agent therapy for the treatment of platinum-resistant ovarian cancer will continue as planned without modification.

  April 26, 2018

   · 

  4 min read
• Deals

  HCP Declares Quarterly Cash Dividend of $0.37 Per Share on Common Stock

  HCP, Inc. (NYSE: HCP) announced that its Board of Directors declared a quarterly common stock cash dividend of $0.37 per share.

  April 26, 2018

   · 

  1 min read
• Deals

  Nu Skin Enterprises Announces Quarterly Dividend of $0.365 Per Share

  Nu Skin Enterprises, Inc. announced its board of directors has declared a quarterly cash dividend of $0.365 per share

  April 26, 2018

   · 

  1 min read
• Business

  BioPharmX Reports Fourth Quarter and Full Year 2018 Financial Results

  BioPharmX Corporation reports financial results for the quarter and year ended January 31, 2018.

  April 26, 2018

   · 

  20 min read
• Business

  Knowles Reports Q1 2018 Financial Results and Provides Outlook for Q2 2018

  Knowles Corporation announced results for the first quarter ended March 31, 2018.

  April 26, 2018

   · 

  16 min read
• Business

  ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2018

  ResMed announced results for its quarter ended March 31, 2018. Revenue for the quarter was $591.6 million, a 15 percent increase compared to the same period of the prior year.

  April 26, 2018

   · 

  15 min read
• Business

  AtriCure Reports First Quarter 2018 Financial Results

  AtriCure, Inc. announced first quarter 2018 financial results.

  April 26, 2018

   · 

  9 min read